Lantern Pharma First Quarter 2024

Media Summary: 00:00 FWS / Agenda 02:53 Introductory remarks - Panna Sharma (CEO) 04:11 Clinical Pipeline Progress - Panna Sharma (CEO) ... Join our discord to talk more about this and many more filings! Discord Link: Everyone is ... Biotech investors and oncology researchers:

Lantern Pharma First Quarter 2024 - Detailed Analysis & Overview

00:00 FWS / Agenda 02:53 Introductory remarks - Panna Sharma (CEO) 04:11 Clinical Pipeline Progress - Panna Sharma (CEO) ... Join our discord to talk more about this and many more filings! Discord Link: Everyone is ... Biotech investors and oncology researchers:

Photo Gallery

Lantern Pharma | First Quarter 2024 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2025 Operating & Financial Results Conference Call

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

Lantern Pharma | Second Quarter 2024 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2023 Operating & Financial Results Conference Call

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma (LTRN|$41.5M) - 2024 Q4 & Full Year Earnings Analysis

My Signal from Lantern Pharma's 8-K Filing

Lantern Pharma's Unique Position and Market Opportunity

Lantern Pharma (Nasdaq: LTRN): Transforming Oncology Drug Development with AI-Powered Precision

View Detailed Profile

Lantern Pharma | First Quarter 2024 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2024 Operating & Financial Results Conference Call

Lantern Pharma's First Quarter

Lantern Pharma | First Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2022 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma | First Quarter 2025 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2025 Operating & Financial Results Conference Call

00:00 FWS / Agenda 02:53 Introductory remarks - Panna Sharma (CEO) 04:11 Clinical Pipeline Progress - Panna Sharma (CEO) ...

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

0:00 Introduction 7:40 4th

Lantern Pharma | Second Quarter 2024 Operating & Financial Results Conference Call

Lantern Pharma | Second Quarter 2024 Operating & Financial Results Conference Call

0:00 Intro 3:40

Lantern Pharma | First Quarter 2023 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2023 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma

Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma (LTRN|$41.5M) - 2024 Q4 & Full Year Earnings Analysis

Lantern Pharma (LTRN|$41.5M) - 2024 Q4 & Full Year Earnings Analysis

LTRN

My Signal from Lantern Pharma's 8-K Filing

My Signal from Lantern Pharma's 8-K Filing

Join our discord to talk more about this and many more filings! Discord Link: https://discord.gg/Dv9DTGayGH Everyone is ...

Lantern Pharma's Unique Position and Market Opportunity

Lantern Pharma's Unique Position and Market Opportunity

Overview of

Lantern Pharma (Nasdaq: LTRN): Transforming Oncology Drug Development with AI-Powered Precision

Lantern Pharma (Nasdaq: LTRN): Transforming Oncology Drug Development with AI-Powered Precision

Lantern Pharma

Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial

Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial

Lantern Pharma

Lantern Pharma | Third Quarter 2024 Operating & Financial Results

Lantern Pharma | Third Quarter 2024 Operating & Financial Results

0:00 Intro 4:42

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Biotech investors and oncology researchers:

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma

RADR® Explained: The AI Engine Powering Lantern Pharma’s Clinical Pipeline

RADR® Explained: The AI Engine Powering Lantern Pharma’s Clinical Pipeline

Lantern Pharma

Lantern Pharma (Nasdaq: LTRN) | The AI Investor Conference Replay

Lantern Pharma (Nasdaq: LTRN) | The AI Investor Conference Replay

At RedChip's AI Investor Conference,

Related Video Content

Lantern | Unlock the full internet information

Lantern outperforms other VPNs in the face of tough network restrictions. We're constantly evolving to ensure you get...

Lantern · GitHub information

Lantern has 471 repositories available. Follow their code on GitHub.

The Specialty Care Platform - Lantern information

Lantern ensures members and their loved ones get the best care. 1 Our specialty care platform focuses exclusively on...

Lantern - Private Internet for All - Amazon Web Services information

Lantern delivers private, fast, reliable and secure access to the open internet. One click to a private and secure...

Download Lantern (free) for Windows, macOS, Android, APK, iOS information

May 22, 2026 · Bypass internet restrictions effortlessly with Lantern—a lightweight, user-friendly tool that ensures...